Biocon Limited has informed the Exchange regarding 'Intimation of change in name of step-down subsidiary of the Company'.
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biocon Limited informed the exchanges that its step-down subsidiary, Biosimilar Collaborations Ireland Limited, has been renamed to Biocon Biologics Ireland Limited with effect from March 27, 2026. This entity sits under Biocon Biologics Limited (BBL), which is a material subsidiary of Biocon. The change was communicated by BBL to Biocon on March 29, 2026. The filing is purely an administrative/intimation update with no impact on business operations or financials.
This is a routine corporate name change at a lower-level subsidiary and is unlikely to have any material effect on Biocon's stock price or shareholder value. It mainly reflects a branding alignment under the Biocon Biologics identity.